ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0123

A Case Series Highlighting Overlap Between PKD-Spectrum Disease and COL4-Related Nephropathies

Session Information

Category: Genetic Diseases of the Kidneys

  • 1202 Genetic Diseases of the Kidneys: Non-Cystic (Complex and Non-Cystic Monogenic)

Authors

  • Abuelsamen, Tamer, University of Utah Health, Salt Lake City, Utah, United States
  • Sameh, Ahmed, University of Utah Health, Salt Lake City, Utah, United States
  • Ludwig, Micah Joseph, Duke University Hospital, Durham, North Carolina, United States
  • Mekki, Ossama, University of Utah Health, Salt Lake City, Utah, United States
  • Al-Rabadi, Laith, University of Utah Health, Salt Lake City, Utah, United States
  • Sparks, Matthew A., Duke University Hospital, Durham, North Carolina, United States
Background

Autosomal dominant polycystic kidney disease (ADPKD) and collagen 4 (COL4)-related nephropathies are traditionally considered distinct disorders. Genomic testing increasingly identifies patients harboring variants in both disease spectrums, resulting in accelerated or atypical presentations.

Methods

We analyzed 4 new patients with concurrent PKD-spectrum and COL4A3–A5 genetic variants. A structured literature review identified 7 additional cases, yielding a cohort of 11 patients.Clinical and genetic data defined genotype–phenotype relationships

Results

Variants involved PKD1, GANAB, and IFT140, with COL4A3–A5 mutations distributed across COL4A3 (5/11, 45%), COL4A5 (4/11, 36%), and COL4A4 (2/11, 18%), including truncating, splice-site, missense, and in-frame deletion classes. Five truncating PKD1 variants were identified, including two in the novel cohort, suggesting enrichment of loss-of-function alleles. Phenotypes were classified as PKD-dominant (27%) and mixed (73%), without isolated COL4-dominant presentations.Hematuria occurred in 83%, proteinuria in 75% (nephrotic range in 25%), and sensorineural hearing loss (SNHL) in 50%. Early-onset disease was prominent, with mean age at presentation of 30.7 years, 42% presenting before age 25, and kidney failure in 50%, with cases before age 20. Initial diagnosis was frequently anchored to ADPKD; however glomerular or extrarenal features prompted reconsideration of COL4-related disease. Discordant features included cystic phenotypes with disproportionate proteinuria, hematuria, and SNHL

Conclusion

Kidney cysts may obscure COL4-related nephropathy while hematuria, proteinuria, and extrarenal features may obscure ADPKD. This bidirectional overlap supports broader genomic testing in patients with discordant features. Coexisting ADPKD-spectrum and COL4A3–A5 variants may drive earlier-onset disease, disproportionate proteinuria, and accelerated kidney failure compared with either disorder alone

Figure. Clinical and genetic overlap between PKD-spectrum disease and COL4-related nephropathies in the combined cohort

Funding

  • Private Foundation Support